Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 3,131,123 | 2,821,051 | 2,951,422 | 2,690,622 | 2,435,381 |
Marketable Securities | 292,243 | 291,661 | 287,543 | 286,500 | 287,044 |
Receivables | 637,994 | 623,788 | 644,879 | 618,188 | 682,968 |
Inventories | 35,937 | 40,876 | 41,995 | 45,869 | 54,502 |
TOTAL | $4,264,433 | $3,971,633 | $4,092,850 | $3,821,111 | $3,625,845 |
Non-Current Assets | |||||
PPE Net | 749,352 | 741,701 | 739,310 | 715,733 | 721,328 |
Investments And Advances | 170,316 | 128,313 | 133,676 | 149,124 | 149,784 |
Intangibles | 134,954 | 140,658 | 129,219 | 134,603 | 139,987 |
Other Non-Current Assets | 889,204 | 815,318 | 745,929 | 689,643 | 682,091 |
TOTAL | $1,943,826 | $1,825,990 | $1,748,134 | $1,689,103 | $1,693,190 |
Total Assets | $6,208,259 | $5,797,623 | $5,840,984 | $5,510,214 | $5,319,035 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 155,538 | 55,633 | 277,546 | 163,175 | 194,770 |
Accrued Expenses | 960,069 | 947,329 | 876,352 | 840,309 | 728,868 |
TOTAL | $1,118,773 | $1,006,111 | $1,157,077 | $1,006,596 | $926,674 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | 319,303 | 299,245 | 283,705 | 246,491 | 276,143 |
TOTAL | $348,794 | $328,944 | $313,788 | $276,967 | $307,300 |
Total Liabilities | $1,467,567 | $1,335,055 | $1,470,865 | $1,283,563 | $1,233,974 |
Shareholders' Equity | |||||
Shares Outstanding, K | 224,088 | 223,088 | 222,965 | 222,476 | 222,431 |
Common Shares | 223 | 223 | 223 | 222 | 222 |
Retained earnings | -211,963 | -415,511 | -437,214 | -465,675 | -578,450 |
Other shareholders' equity | 26,806 | 20,942 | 15,069 | -29,062 | -25,696 |
TOTAL | $4,740,692 | $4,462,568 | $4,370,119 | $4,226,651 | $4,085,061 |
Total Liabilities And Equity | $6,208,259 | $5,797,623 | $5,840,984 | $5,510,214 | $5,319,035 |